Article info

Original research
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis

Authors

  1. Correspondence to Professor Martin R Turner, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK; martin.turner{at}ndcn.ox.ac.uk
View Full Text

Citation

Thompson AG, Talbot K, Turner MR
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis

Publication history

  • Received May 13, 2021
  • Accepted August 8, 2021
  • First published September 13, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.